Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report

Published:2012-06 Issue:3 Volume:25 Page:117-139
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Evans Carole¹,Cipolla David²,Chesworth Tim³,Agurell Eva⁴,Ahrens Richard⁵,Conner Dale⁶,Dissanayake Sanjeeva⁷,Dolovich Myrna⁸,Doub William⁹,Fuglsang Anders¹⁰,García Arieta Afredo¹¹,Golden Michael¹²,Hermann Robert¹³,Hochhaus Günther¹⁴,Holmes Susan¹⁵,Lafferty Paul¹⁶,Lyapustina Svetlana¹⁷,Nair Parameswaran⁸,O'Connor Dennis¹⁸,Parkins David¹⁹,Peterson Ilse¹⁷,Reisner Colin²⁰,Sandell Dennis²¹,Singh Gur Jai Pal²²,Weda Marjolein²³,Watson Patricia¹⁹

Affiliation:

1. Catalent Pharma Solutions, Research Triangle Park, North Carolina.

2. Aradigm, Hayward, California.

3. AstraZeneca, Macclesfield, United Kingdom.

4. Swedish Medical Products Agency, Uppsala, Sweden.

5. University of Iowa, Iowa City, Iowa.

6. U.S. FDA, Rockville, Maryland.

7. Mundipharma Research, Cambridge, United Kingdom.

8. McMaster University, Hamilton, Ontario, Canada.

9. U.S. FDA, St. Louis, Missouri.

10. Fuglsang Pharma, Rudolstadt, Germany.

11. Spanish Agency for Medicines and Health Care Products, Madrid, Spain.

12. Pearl Therapeutics, Raleigh, North Carolina.

13. Clinical Research Appliance (cr.appliance), Radolfzell, Germany.

14. Univeristy of Florida, Gainesville, Florida.

15. GlaxoSmithKline R&D, Research Triangle Park, North Carolina.

16. Medical Technology Consulting, Hemel Hempstead, United Kingdom.

17. Drinker Biddle & Reath, Washington, DC.

18. Boehringer Ingelheim, Ridgefield, Connecticut.

19. GlaxoSmithKline R&D, Ware, United Kingdom.

20. Pearl Therapeutics, Morristown, New Jersey.

21. S5 Consulting, Lund, Sweden.

22. AXAR Pharmaceuticals, Corona, California.

23. National Institute for Public Health and the Environment (rivm), Bilthoven, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jamp.2011.0968

Reference70 articles.

1. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report

2. Role of Pharmacokinetics in Establishing Bioequivalence for Orally Inhaled Drug Products: Workshop Summary Report

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2;ERJ Open Research;2024-01

2. Microstructural insight into inhalation powder blends through correlative multi-scale X-ray computed tomography;European Journal of Pharmaceutics and Biopharmaceutics;2023-10

3. Advances and future perspectives in epithelial drug delivery;Advanced Drug Delivery Reviews;2022-07

4. Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations;Pharmaceutics;2022-03-31

5. Fine Particle Fraction: The Good and the Bad;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2022-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3